Document is current
Any future updates will be listed below
-
Authors
Dardaei, Leila
Wang, Hui Qin
Singh, Manrose
Fordjour, Paul
Shaw, Katherine X
Yoda, Satoshi http://orcid.org/0000-0003-4201-1392
Kerr, Grainne
Yu, Kristine
Liang, Jinsheng
Cao, Yichen
Chen, Yan
Lawrence, Michael S
Langenbucher, Adam
Gainor, Justin F
Friboulet, Luc http://orcid.org/0000-0002-1129-4978
Dagogo-Jack, Ibiayi
Myers, David T
Labrot, Emma
Ruddy, David
Parks, Melissa
Lee, Dana
DiCecca, Richard H
Moody, Susan
Hao, Huaixiang
Mohseni, Morvarid
LaMarche, Matthew
Williams, Juliet
Hoffmaster, Keith
Caponigro, Giordano
Shaw, Alice T
Hata, Aaron N
Benes, Cyril H
Li, Fang
Engelman, Jeffrey A
- License Information
-
More Information
Article History
Received: 26 May 2017
Accepted: 17 January 2018
First Online: 5 March 2018
Competing interests
: H.Q.W., P.F., G.K., K.Y., J.L., Y. Cao, Y. Chen, E.L., D.R., S.M., H.H., M.M., M.L., J.W., K.H., G.C., F.L. and J.A.E. are employees of Novartis. J.F.G. has served as a compensated consultant or received honoraria from Bristol-Myers Squibb, Genentech, Ariad, Loxo, Incyte, Novartis, Merck and Clovis. A.T.S. has served as a compensated consultant or received honoraria from Pfizer, Novartis, Genentech, Roche, Ignyta, Blueprint Medicine, Daiichi-Sankyo, Ariad, Chugai, Taiho Pharmaceuticals and EMD Serono. C.H.B. has received research funding from Novartis and Amgen. A.N.H. has received research funding from Novartis, Relay Therapeutics and Amgen. The remaining authors have no financial interests to declare.
